Parkway Life Real Estate Investment (PRKWF) AI Stock Analysis

• Market Cap: $2.05B
• Dividend Yield: 3.54%
• Average Volume (3M): 147.00
• Price to Earnings (P/E): 27.2
• Beta (1Y): 0.24
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 23
• Sector: Real Estate
• Sector Strength: 60
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.12
• Shares Outstanding: 652,420,400
• 10 Day Avg. Volume: 23
• 30 Day Avg. Volume: 147
• PEG Ratio: 0.15
• Price to Book (P/B): 1.58
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 28.75
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $1.32
• Price Target Upside: -58.10% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

Positive Factors

Earnings Growth

Successful asset recycling activities in Japan have been delivering steady growth for PLife REIT.

Market Position

Parkway Life REIT is a rare jewel amongst SREITs in a defensive industry offering high-quality earnings visibility.

Strategic Expansion

The acquisition of 11 nursing homes in France represents a strategic entry into a third core market, providing an NPI yield of 6.5%.

Negative Factors

Currency Risks

PLife REIT derives c.40% of its earnings from healthcare assets in Japan and is exposed to foreign exchange volatility.

Finance Costs

Finance costs have increased 14.9% due to funding of capex for Project Renaissance and new acquisitions as well as higher interest costs from SGD-denominated debts.

Parkway Life Real Estate Investment Business Overview & Revenue Model

Company Description

Parkway Life Real Estate Investment Trust ("PLife REIT") is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020. It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.

How the Company Makes Money

Parkway Life Real Estate Investment Financial Statement Overview

Summary

Parkway Life Real Estate Investment exhibits a strong financial position with robust profitability and efficient cash flow management. While revenue growth has faced challenges, the company maintains healthy margins and a balanced leverage strategy, positioning it well within the REIT - Healthcare Facilities industry.

Income Statement

The company demonstrates strong profitability with a consistent gross profit margin. However, while the net profit margin is healthy, recent revenue growth is slightly negative, indicating potential challenges in maintaining top-line growth. EBIT margin is unavailable, but EBITDA margin remains robust, reflecting efficient operations.

Balance Sheet

The balance sheet presents a stable equity ratio, indicating a solid equity position relative to total assets. The debt-to-equity ratio is moderate, reflecting a balanced approach to leverage. Return on equity is strong, suggesting effective use of equity to generate profits.

Cash Flow

Operating cash flow remains strong, supporting net income well. However, free cash flow growth has been inconsistent, with a decline in the most recent year. The free cash flow to net income ratio is solid, indicating good cash conversion from earnings.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
145.49M	153.49M	147.47M	129.97M	120.70M	120.89M
	Gross Profit
112.64M	126.74M	124.59M	121.87M	111.23M	112.53M
	EBIT
114.48M	131.41M	121.58M	49.16M	335.65M	102.55M
	EBITDA
-3.29M	113.88M	121.20M	112.14M	344.92M	101.73M
	Net Income Common Stockholders
104.88M	95.04M	100.47M	41.14M	331.88M	87.22M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
25.79M	29.47M	28.50M	40.01M	25.79M	22.66M
	Total Assets
2.35B	2.55B	2.33B	2.34B	2.35B	2.07B
	Total Debt
828.01M	886.11M	828.47M	851.89M	828.01M	793.65M
	Net Debt
802.21M	856.64M	799.97M	811.88M	802.21M	770.99M
	Total Liabilities
910.43M	981.20M	919.58M	931.66M	910.43M	883.36M
	Stockholders Equity
1.43B	1.57B	1.41B	1.41B	1.43B	1.18B
Cash Flow		Free Cash Flow
0.00	46.68M	77.65M	30.74M	78.17M	85.73M
	Operating Cash Flow
0.00	95.79M	108.69M	94.63M	89.86M	90.31M
	Investing Cash Flow
0.00	-239.93M	-49.56M	-125.18M	-74.99M	-28.57M
	Financing Cash Flow
0.00	147.35M	-67.92M	47.75M	-9.98M	-61.46M

Parkway Life Real Estate Investment Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PRKWF		$2.05B	27.16	6.39%	3.54%	―	―
Sector *	61 Neutral	$2.83B	10.92	0.41%	8438.90%	5.75%	-21.03%
CGIUF		$1.40B	―	-6.38%	9.43%	―	―
FSRPF		$2.53B	12.81	2.80%	5.24%	―	―
SPHEF		$2.15B	34.72	11.74%	1.24%	―	―
SURVF		$2.58B	30.20	1.86%	5.31%	―	―
TS0U	55 Neutral	S$1.54B	8.06	-1.97%	4.04%	-1.51%	-135.46%